CUSIP 045396207COM NEWASMBQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
69 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 4.51M | $153.23M | 0 | Held |
| 2 | Farallon Capital Management LLC | 1.23M | $41.75M | 0 | Held |
| 3 | Ra Capital Management, L.P. | 1.02M | $34.70M | 0 | Held |
| 4 | Commodore Capital LP | 1.00M | $34.01M |
| 0 |
| Held |
| 5 | Janus Henderson Group PLC | 837.9K | $28.54M | +85.3K | Added |
| 6 | Paradigm Biocapital Advisors LP | 665.3K | $22.63M | +665.3K | New |
| 7 | Point72 Asset Management, L.P. | 600.6K | $20.43M | +304.6K | Added |
| 8 | Vanguard Group Inc | 572.9K | $19.48M | +70.8K | Added |
| 9 | Blackstone Inc. | 318.8K | $10.84M | −129.0K | Reduced |
| 10 | Parkman Healthcare Partners LLC | 249.4K | $8.48M | −1.6K | Reduced |
See every fund holding Assembly Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders